Cargando…
Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
BACKGROUND: Oncogenic mutations are powerful predictive biomarkers for molecularly targeted cancer therapies. For mutation detection patients have to undergo invasive tumor biopsies. Alternatively, archival samples are used which may no longer reflect the actual tumor status. Circulating tumor cells...
Autores principales: | Breitenbuecher, Frank, Hoffarth, Sandra, Worm, Karl, Cortes-Incio, Diana, Gauler, Thomas C., Köhler, Jens, Herold, Thomas, Schmid, Kurt Werner, Freitag, Lutz, Kasper, Stefan, Schuler, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897440/ https://www.ncbi.nlm.nih.gov/pubmed/24465542 http://dx.doi.org/10.1371/journal.pone.0085350 |
Ejemplares similares
-
Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
por: Pogorzelski, M, et al.
Publicado: (2014) -
Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
por: Kasper, S, et al.
Publicado: (2012) -
Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity
por: Göbel, C, et al.
Publicado: (2014) -
Circulating Tumor Cell Composition in Renal Cell Carcinoma
por: Nel, Ivonne, et al.
Publicado: (2016) -
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
por: Kasper, Stefan, et al.
Publicado: (2017)